olmesartan has been researched along with AIDS Nephropathy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hiramatsu, N; Hiromura, K; Ideura, H; Ikeuchi, H; Kaneko, Y; Kopp, JB; Kuroiwa, T; Nojima, Y; Sakurai, N; Shigehara, T; Takeuchi, S; Tomioka, M; Ueki, K | 1 |
1 other study(ies) available for olmesartan and AIDS Nephropathy
Article | Year |
---|---|
Angiotensin II type 1 receptor blockade inhibits the development and progression of HIV-associated nephropathy in a mouse model.
Topics: AIDS-Associated Nephropathy; Angiotensin II Type 1 Receptor Blockers; Animals; Black People; Disease Models, Animal; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; Kidney; Kidney Failure, Chronic; Membrane Proteins; Mice; Mice, Transgenic; Receptor, Angiotensin, Type 1; Tetrazoles | 2007 |